Characterization of novel inhibitors of G1-S phase progression in Drosophila
Characterization of novel inhibitors of G1-S phase progression in Drosophila
批准号:
nhmrc : 350369
负责人:
A/Pr Helena Richardson
金额:
$30.41万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2005
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2005-01-01 至 2007-12-31
中文摘要
癌症是一种影响1-3人的疾病,因此,了解癌症发生的机制对医学科学至关重要。癌症通过改变正常细胞增殖控制、分化、细胞死亡或细胞运动的突变的积累而产生。许多与癌症有关的基因已经被鉴定出来,然而,可能还有更多的基因,当被破坏或错误表达时,可能会导致癌症。我们对细胞增殖的调节很感兴趣,并且一直在遗传学上适合的动物模型系统中研究这一点,醋蝇,果蝇。在所有多细胞生物体中,细胞增殖的关键调节因子是细胞周期蛋白E,它是驱动细胞从G1期(静止状态)进入S期(DNA复制发生)所必需的。细胞周期蛋白E的正确控制在限制细胞增殖中是重要的,许多致癌突变导致这种关键细胞周期调节因子的上调。我们已经使用了遗传学的方法来确定新的负调控细胞周期蛋白E。该提案旨在进一步阐明已鉴定的细胞周期蛋白E相互作用物调节细胞周期进程的机制。此外,该提案旨在确定其他细胞周期蛋白E相互作用的编码基因,有望成为新的肿瘤抑制因子。该项目的预期成果是阐明在整个生物体中控制细胞增殖的新基因和机制。由于细胞增殖和信号蛋白的保守性,这一提议与理解人类癌症有关。
英文摘要
Cancer is a disease that affects 1-3 people and therefore, understanding the mechanisms by which cancer arises is of major importance to medical science. Cancers arise through the accumulation of mutations that alter normal cell proliferation control, differentiation, cell death or cell movement. Many genes involved in cancer have been identified, however, there are likely to be many more genes, that when disrupted or misexpressed can lead to cancer. We are interested in the regulation of cell proliferation, and have been studying this in the genetically amenable animal model system, the vinegar fly, Drosophila. A key regulator of cell proliferation in all multicellular organisms is Cyclin E, which is required to drive cells from the G1 (resting state) into S phase (where DNA replication occurs). Correct control of Cyclin E is important in limiting cell proliferation and many cancer-causing mutations result in up-regulation of this critical cell cycle regulator. We have used a genetic approach to identify novel negative regulators of Cyclin E. This proposal seeks to further clarify the mechanism by which the identified Cyclin E interactors regulate cell cycle progression. In addition, this proposal seeks to identify the genes encoding other cyclin E interactors, expected to be novel tumor suppressors. The expected outcome of this project is to elucidate novel genes and mechanisms that control cell proliferation in the context of a whole organism. Due to the conservation of cell proliferation and signalling proteins, this proposal is relevant to understanding human cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deciphering the role of Scribble in Development and Disease
-
批准号:nhmrc : 1103871
-
项目类别:Project Grants
-
资助金额:$43.02万
-
财政年份:2016
-
负责人:A/Pr Helena Richardson
-
依托单位:
Deciphering the role of Scribble in Development and Disease
-
批准号:nhmrc : GNT1103871
-
项目类别:Project Grants
-
资助金额:$62.88万
-
财政年份:2016
-
负责人:A/Pr Helena Richardson
-
依托单位:
Research Fellowship
-
批准号:nhmrc : 1020056
-
项目类别:Research Fellowships
-
资助金额:$45.06万
-
财政年份:2012
-
负责人:A/Pr Helena Richardson
-
依托单位:
Identification of novel tumour suppressors in Ras-mediated tumourigenesis
-
批准号:nhmrc : 1020525
-
项目类别:Project Grants
-
资助金额:$38.71万
-
财政年份:2012
-
负责人:A/Pr Helena Richardson
-
依托单位:
Control of the Ras/Erk signaling pathway by the Brahma chromatin-remodeling complex
-
批准号:nhmrc : 1011320
-
项目类别:NHMRC Project Grants
-
资助金额:$35.0万
-
财政年份:2011
-
负责人:A/Pr Helena Richardson
-
依托单位:
The mechanism by which apical-basal polarity complexes regulate the Salvador-Warts-Hippo pathway
-
批准号:nhmrc : 628401
-
项目类别:NHMRC Project Grants
-
资助金额:$36.01万
-
财政年份:2010
-
负责人:A/Pr Helena Richardson
-
依托单位:
The tumour suppressor Lgl in the regulation of cell signaling, proliferation and apoptosis
-
批准号:nhmrc : 509020
-
项目类别:NHMRC Project Grants
-
资助金额:$35.67万
-
财政年份:2008
-
负责人:A/Pr Helena Richardson
-
依托单位:
Research Fellowship - Grant ID:454700
-
批准号:nhmrc : 454700
-
项目类别:NHMRC Research Fellowships
-
资助金额:$41.26万
-
财政年份:2007
-
负责人:A/Pr Helena Richardson
-
依托单位:
SPARC and SPARC cluster genes in tumourigenesis.
-
批准号:nhmrc : 454557
-
项目类别:NHMRC Project Grants
-
资助金额:$33.57万
-
财政年份:2007
-
负责人:A/Pr Helena Richardson
-
依托单位:
Characterisation of cooperation between cell polarity regulators and oncogenes in tumourigenesis using Drosophila
-
批准号:nhmrc : 400211
-
项目类别:NHMRC Project Grants
-
资助金额:$20.32万
-
财政年份:2006
-
负责人:A/Pr Helena Richardson
-
依托单位:
Analysis of the Scrib, Dlg and Lgl tumour suppressors in cell cycle regulation using the Drosophila animal model system
-
批准号:nhmrc : 299956
-
项目类别:NHMRC Project Grants
-
资助金额:$31.77万
-
财政年份:2004
-
负责人:A/Pr Helena Richardson
-
依托单位:
Uncoupled Research Fellowship
-
批准号:nhmrc : 299842
-
项目类别:NHMRC Research Fellowships
-
资助金额:$22.48万
-
财政年份:2004
-
负责人:A/Pr Helena Richardson
-
依托单位:
THE ROLE OF A NOVEL NEGATIVE CELL CYCLE REGULATORY PATHWAY DURING ANIMAL DEVELOPMENT
-
批准号:nhmrc : 209018
-
项目类别:NHMRC Project Grants
-
资助金额:$27.14万
-
财政年份:2002
-
负责人:A/Pr Helena Richardson
-
依托单位:
Molecular Regulation of Programmed Cell Death
-
批准号:nhmrc : 157920
-
项目类别:NHMRC Project Grants
-
资助金额:$49.57万
-
财政年份:2001
-
负责人:A/Pr Helena Richardson
-
依托单位:
THE ROLE OF NOVEL TUMOUR SUPPRESSORS DURING DEVELOPMENT
-
批准号:nhmrc : 104919
-
项目类别:NHMRC Project Grants
-
资助金额:$13.39万
-
财政年份:2000
-
负责人:A/Pr Helena Richardson
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Novel-miR-1134调控LHCGR的表达介导拟
穴青蟹卵巢发育的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:崔文晓
-
依托单位:
miR-2796和novel_13靶向磷脂酶C基因调控Q烟粉虱高温耐受性的分子机制
-
批准号:32402377
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2024
-
负责人:戴恬美
-
依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
-
批准号:82304677
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:边兴博
-
依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
-
批准号:82304658
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘亚
-
依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
-
批准号:32102747
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李婉雁
-
依托单位:
novel_circ_001042/miR-298-5p/Capn1轴调节线粒体能量代谢在先天性肛门直肠畸形发生中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:唐晓冰
-
依托单位:
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:张瑜
-
依托单位:
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
-
批准号:82070530
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:白玉作
-
依托单位:
miRNA-novel-272通过靶向半乳糖凝集素3调控牙鲆肠道上皮细胞炎症反应的机制研究
-
批准号:32002421
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:修云吉
-
依托单位:
m6A修饰介导的lncRNA WEE2-AS1转录后novel-pri-miRNA剪切机制在胶质瘤恶性进展中的作用研究
-
批准号:82072775
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:薛皓
-
依托单位: